Search Orphan Drug Designations and Approvals
-
Generic Name: | Recombinant human insulin-like growth factor-I |
---|---|
Date Designated: | 02/16/2000 |
Orphan Designation: | Treatment of short-bowel syndrome as a result of resection of the small bowel or as a result of congenital dysfunction of the intestines. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
GroPep Pty Ltd. Gate 11, Victoria Dr. Adelaide SA 5000 Australia The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-